Anti-Müllerian Hormone: A Predictor of Successful Intrauterine Insemination.
anti-mullerian hormone
female infertility
intrauterine insemination
ovarian stimulation
pregnancy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
accepted:
16
10
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
The anti-Müllerian hormone (AMH) produced by the granulosa cells of ovarian follicles has been shown to correlate with ovarian reserve and is often measured for fertility therapies. In this study, we evaluated the relationship between serum AMH values and the clinical pregnancy (CP) rates of female partners with unexplained infertility undergoing intrauterine insemination utilizing varying ovarian simulation protocols. This is a retrospective cohort study conducted among couples who underwent intrauterine insemination therapy over a period of four years at Charleston Area Medical Center, a tertiary care medical center in West Virginia, USA. Logistic regression was used to determine the best predictor of CP. A total of 509 intrauterine inseminations resulting in 81 (15.9%) Cps were analyzed. The cycles with a CP had higher mean AMH values (3.7+3.5 vs. 2.2+2.1; p<0.001). The majority of patients were nulliparous (77.0%) with a mean age of 33.6+5.0 years. After including only patients with unexplained infertility (the predominate infertility diagnosis; n=255 (50.1% of the cycles)) and stimulation cycles >10, the final sample size for the analysis was 245/509=48.1%. Following a receiver operating characteristic (ROC) curve analysis, the optimal AMH cut-off point was 2.1 ng/mL with an area under the curve (AUC) equal to 0.61 and 95% confidence intervals (CIs) of 0.55- 0.67 (p=0.002). The CP rate was significantly higher with the AMH >2.1 ng/mL (20.0%) compared to <2.1 ng/mL (10.0%; p=0.041). With Clomid/human gonadotropins/human chorionic gonadotropin (hCG) trigger treatment, the CP rate quadrupled (odds ratio (OR): 4.6; 95% CI: 2.1-9.7; p<0.001). This study indicates that higher AMH levels and a more aggressive ovarian stimulation protocol for intrauterine insemination therapy (IUI) have a better probability of resulting in CP.
Identifiants
pubmed: 38022255
doi: 10.7759/cureus.47200
pmc: PMC10652159
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e47200Informations de copyright
Copyright © 2023, Stalzer et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Fertil Steril. 2006 Mar;85(3):592-6
pubmed: 16500324
Fertil Steril. 2002 Mar;77(3):468-71
pubmed: 11872196
Fertil Steril. 2010 Dec;94(7):2824-7
pubmed: 20538269
Aust N Z J Obstet Gynaecol. 2010 Dec;50(6):568-72
pubmed: 21133869
Fertil Steril. 2010 Nov;94(6):2177-81
pubmed: 20171627
J Obstet Gynaecol Can. 2017 Oct;39(10):880-885
pubmed: 28647445
Fertil Steril. 2008 Sep;90(3):737-43
pubmed: 17923131
J Clin Endocrinol Metab. 2006 Oct;91(10):4057-63
pubmed: 16804046
J Chin Med Assoc. 2019 Apr;82(4):300-304
pubmed: 30946209
Hum Reprod. 2002 Dec;17(12):3065-71
pubmed: 12456604
Clin Chim Acta. 2014 Nov 1;437:175-82
pubmed: 25086280
Hum Reprod. 1999 Mar;14(3):698-703
pubmed: 10221698
Int J Gynaecol Obstet. 2016 Apr;133(1):64-8
pubmed: 26873125
Hum Reprod. 2018 Aug 1;33(8):1489-1498
pubmed: 30010882
Hum Reprod. 2005 Apr;20(4):915-22
pubmed: 15665015
Arch Gynecol Obstet. 2021 May;303(5):1207-1216
pubmed: 33247770
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Reprod Biol. 2014 Sep;14(3):176-81
pubmed: 25152514
Fertil Steril. 2015 Jan;103(1):119-30.e3
pubmed: 25450298
BJOG. 2005 Oct;112(10):1384-90
pubmed: 16167941
Sci Rep. 2020 Nov 12;10(1):19750
pubmed: 33184364
Front Endocrinol (Lausanne). 2020 Dec 04;11:595448
pubmed: 33343511
Fertil Steril. 2020 Apr;113(4):788-796.e4
pubmed: 32147173
Gynecol Endocrinol. 2015 Oct;31(10):765-8
pubmed: 26288100
Reprod Biomed Online. 2010 May;20(5):582-7
pubmed: 20303323
Hum Reprod. 2008 Jun;23(6):1359-65
pubmed: 18387961
J Reprod Med. 2008 Mar;53(3):196-202
pubmed: 18441725
Ultrasound Obstet Gynecol. 2005 Dec;26(7):699-706
pubmed: 16308893